Zeiss Vision Care has announced that it has signed a definitive agreement to acquire a 10% stake in Ocumeda AG from Fielmann Group for €10m, with the intention to acquire up to a 25% stake. The transaction values Ocumeda at €100m. Marc Fielmann, Ceo of Fielmann Group: “We are excited to welcome Zeiss Vision Care as a strategic investor in Ocumeda. This partnership marks an important milestone in Fielmann Group’s Vision 2035 growth strategy, which aims to make primary eyecare accessible and affordable. This way we pursue our purpose that help everyone hear and see the beauty in the world.”

November 2025